Characterization of cytokinome landscape for clinical responses in human cancers

OncoImmunology

Volumn 5, Issue 11, 2016, Pages

  Wong, Henry Sung Ching ^a   Chang, Che Mai ^a   Liu, Xiao ^b   Huang, Wan Chen ^c,d   Chang, Wei Chiao ^a,e  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b UNIVERSITY OF CHICAGO   (United States)

^c INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

cytokines and chemokines; Cytokinome landscape; drug target enrichment; pan cancer analysis; survival analysis; transcription profiles

Indexed keywords

CXCL14 CHEMOKINE; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; BREAST CANCER; CANCER STAGING; CONCENTRATION (PARAMETERS); CYTOKINOME; DOWN REGULATION; GENE; GENE EXPRESSION; HUMAN; IMMUNOPATHOGENESIS; META ANALYSIS; MOLECULAR BIOLOGY; MOLECULAR GENETICS; NEOPLASM; PROTEIN CODING GENE; SURVIVAL; TARGET CELL;

EID: 84994067316     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2016.1214789     Document Type: Article

References (38)

1. Melief CJ, Finn OJ. Cancer immunology. Curr Opin Immunol 2011; 23:234-6; PMID:21292460; doi:10.1016/j.coi.2011.01.003
2. Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 2013; 14:1014-22; PMID:24048123; doi:10.1038/ni.2703
3. Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 2004; 4:11-22; PMID:14708024; doi:10.1038/nrc1252
4. Wang D, Dubois RN, Richmond A. The role of chemokines in intestinal inflammation and cancer. Curr Opin Pharmacol 2009; 9:688-96; PMID:19734090; doi:10.1016/j.coph.2009.08.003
5. Gonzalez-Navajas JM, Lee J, David M, Raz E. Immunomodulatory functions of type I interferons. Nat Rev Immunol 2012; 12:125-35; PMID:22222875; doi:10.1038/nri3133
6. Lippitz BE. Cytokine patterns in patients with cancer:a systematic review. Lancet Oncol 2013; 14:e218-28; PMID:23639322; doi:10.1016/S1470-2045(12)70582-X
7. Wang E, Panelli MC, Monsurro V, Marincola FM. A global approach to tumor immunology. Cell Mol Immunol 2004; 1:256-65; PMID:16225768
8. Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting:integrating immunity's roles in cancer suppression and promotion. Science 2011; 331:1565-70; PMID:21436444; doi:10.1126/science.1203486
9. Bonecchi R, Locati M, Mantovani A. Chemokines and cancer:a fatal attraction. Cancer Cell 2011; 19:434-5; PMID:21481784; doi:10.1016/j.ccr.2011.03.017
10. Gabrilovich D. Fatal attraction:How macrophages participate in tumor metastases. J Exp Med 2015; 212:976; PMID:26122939; doi:10.1084/jem.2127insight1
11. Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, Kochi Y, Ohmura K, Suzuki A, Yoshida S, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2014; 506:376-81; PMID:24390342; doi:10.1038/nature12873
12. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M. DrugBank:a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 2008; 36:D901-6; PMID:18048412; doi:10.1093/nar/gkm958
13. Chen X, Ji ZL, Chen YZ. TTD:Therapeutic target database. Nucleic Acids Res 2002; 30:412-5; PMID:11752352; doi:10.1093/nar/30.1.412
14. Hanahan D, Weinberg RA. Hallmarks of cancer:the next generation. Cell 2011; 144:646-74; PMID:21376230; doi:10.1016/j.cell.2011.02.013
15. Capone F, Guerriero E, Colonna G, Maio P, Mangia A, Marfella R, Paolisso G, Izzo F, Potenza N, Tomeo L, et al. The cytokinome profile in patients with hepatocellular carcinoma and Type 2 diabetes. PLoS One 2015; 10 e0134594; PMID:26226632; doi:10.1371/journal.pone.0134594
16. Mlecnik B, Bindea G, Angell HK, Sasso MS, Obenauf AC, Fredriksen T, Lafontaine L, Bilocq AM, Kirilovsky A, Tosolini M. et al. Functional network pipeline reveals genetic determinants associated with in situ lymphocyte proliferation and survival of cancer patients. Sci Transl Med 2014; 6:228ra37; PMID:24648340; doi:10.1126/scitranslmed.3007240
17. Cohen RL, Settleman J. From cancer genomics to precision oncology-tissue's still an issue. Cell 2014; 157:1509-14; PMID:24949964; doi:10.1016/j.cell.2014.05.027
18. Paradkar PH, Joshi JV, Mertia PN, Agashe SV, Vaidya RA. Role of cytokines in genesis, progression and prognosis of cervical cancer. Asian Pac J Cancer Prev 2014; 15:3851-64; PMID:24935564; doi:10.7314/APJCP.2014.15.9.3851
19. Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 2013; 39:782-95; PMID:24138885; doi:10.1016/j.immuni.2013.10.003
20. Costantini S, Castello G, Colonna G. Human Cytokinome:a new challenge for systems biology. Bioinformation 2010; 5:166-7; PMID:21364780; doi:10.6026/97320630005166
21. Cancer Genome Atlas Research, N. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014; 507:315-22; PMID:24476821; doi:10.1038/nature12965
22. Cancer Genome Atlas, N. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490 61-70; PMID:23000897; doi:10.1038/nature11412
23. Cancer Genome Atlas, N. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487:330-7; PMID:22810696; doi:10.1038/nature11252
24. Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, et al. The somatic genomic landscape of glioblastoma. Cell 2013; 155 462-77; PMID:24120142; doi:10.1016/j.cell.2013.09.034
25. Cancer Genome Atlas, N. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 2015; 517 576-82; PMID:25631445; doi:10.1038/nature14129
26. Cancer Genome Atlas Research, N. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013; 499:43-9; PMID:23792563; doi:10.1038/nature12222
27. Cancer Genome Atlas Research, N, Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, Wheeler DA, Murray BA, Schmidt L, et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. N Engl J Med 2016; 374:135-45; PMID:26536169; doi:10.1056/NEJMoa1505917
28. Cancer Genome Atlas Research, N. Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 2015; 372:2481-98; PMID:26061751; doi:10.1056/NEJMoa1402121
29. Cancer Genome Atlas Research, N. Comprehensive molecular profiling of lung adenocarcinoma. Nature 2014; 511:543-50; PMID:25079552; doi:10.1038/nature13385
30. Cancer Genome Atlas Research, N. Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012; 489:519-25; PMID:22960745; doi:10.1038/nature11404
31. Cancer Genome Atlas Research, N. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474:609-15; PMID:21720365; doi:10.1038/nature10166
32. Cancer Genome Atlas Research, N. The molecular taxonomy of primary prostate cancer. Cell 2015; 163:1011-25; PMID:26544944; doi:10.1016/j.cell.2015.10.025
33. Cancer Genome Atlas Research, N. Integrated genomic characterization of papillary thyroid carcinoma. Cell 2014; 159:676-90; PMID:25417114; doi:10.1016/j.cell.2014.09.050
34. Cancer Genome Atlas Research, N. Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, et al. Integrated genomic characterization of endometrial carcinoma. Nature 2013; 497:67-73; PMID:23636398; doi:10.1038/nature12113
35. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015; 43:e47; PMID:25605792; doi:10.1093/nar/gkv007
36. Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao SD, Zhang Y, Yang L, Shan W, He Q, et al. Comprehensive genomic characterization of long non-coding RNAs across human cancers. Cancer Cell 2015; 28:529-40; PMID:26461095; doi:10.1016/j.ccell.2015.09.006
37. Paradis E, Claude J, Strimmer K. APE:Analyses of phylogenetics and evolution in R language. Bioinformatics 2004; 20:289-90; PMID:14734327; doi:10.1093/bioinformatics/btg412
38. Gharaibeh RZ, Fodor AA, Gibas CJ. Background correction using dinucleotide affinities improves the performance of GCRMA. BMC Bioinformatics 2008; 9:452; PMID:18947404; doi:10.1186/1471-2105-9-452